These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 22473769)
21. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538 [TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid biomarkers in Progranulin mutations carriers. Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865 [TBL] [Abstract][Full Text] [Related]
23. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease. Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468 [TBL] [Abstract][Full Text] [Related]
24. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients. Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793 [TBL] [Abstract][Full Text] [Related]
25. CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. Chiasserini D; Parnetti L; Andreasson U; Zetterberg H; Giannandrea D; Calabresi P; Blennow K J Alzheimers Dis; 2010; 22(4):1281-8. PubMed ID: 20930282 [TBL] [Abstract][Full Text] [Related]
26. Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease. Santos AN; Ewers M; Minthon L; Simm A; Silber RE; Blennow K; Prvulovic D; Hansson O; Hampel H J Alzheimers Dis; 2012; 29(1):171-6. PubMed ID: 22214781 [TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Clark CM; Xie S; Chittams J; Ewbank D; Peskind E; Galasko D; Morris JC; McKeel DW; Farlow M; Weitlauf SL; Quinn J; Kaye J; Knopman D; Arai H; Doody RS; DeCarli C; Leight S; Lee VM; Trojanowski JQ Arch Neurol; 2003 Dec; 60(12):1696-702. PubMed ID: 14676043 [TBL] [Abstract][Full Text] [Related]
28. Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults. Stomrud E; Hansson O; Zetterberg H; Blennow K; Minthon L; Londos E Arch Neurol; 2010 Feb; 67(2):217-23. PubMed ID: 20142530 [TBL] [Abstract][Full Text] [Related]